A Study of Ga-68 Dolacga to Evaluate Liver Reserve Function in Patients With HCC Before and After Proton Therapy
NCT06182865
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Hepatic Carcinoma
Interventions
DRUG:
Ga-68 Dolacga Injection
Sponsor
National Atomic Research Institute, Taiwan